ProCE Banner Events

Share

Managing Patients With High-Risk Hepatocellular Carcinoma: Critical Considerations for the Interdisciplinary Team

Join us for a live, 1-hour CME/CNE/CPE-certified workshop series and engage with an expert who will discuss current and emerging strategies in the management of high-risk hepatocellular carcinoma (HCC).

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Registration not open

Who Should Attend

This educational program is intended for oncology physicians, surgeons, hepatologists, interventional radiologists and other healthcare professionals who care for patients with hepatocellular carcinoma.

Time and location

Tuesday, February 20, 2024

6:00 PM - 7:00 PM Central Time (CT)

Virtual

Virtual Event | Host Group in ND
Grand Forks, North Dakota

Agenda

Welcome and Introduction

Overview of HCC Pathogenesis, Staging, and Definition of High Risk

Treatment of High-Risk Early-Stage HCC

Emerging Adjuvant Therapies for High-Risk HCC

Final Thoughts and Audience Question and Answer Session

Location

Venue Name

Virtual Event | Host Group in ND

Address

Virtual Event | Host Group in ND
Grand Forks, North Dakota

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with high-risk HCC. 

Target Audience
This educational program is intended for oncology physicians, surgeons, hepatologists, interventional radiologists and other healthcare professionals who care for patients with hepatocellular carcinoma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain to colleagues and patients key factors that determine a patient with HCC to be at high risk of recurrence, including pathogenesis and staging
  • Plan a personalized therapeutic strategy for patients with early-stage HCC at high risk of recurrence considering all available treatment modalities and expert recommendations regarding timing and sequencing of therapy
  • Assess the rationale and available clinical trial data evaluating the use of immune checkpoint inhibitors for patients with high-risk HCC in the adjuvant setting

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-027-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Genentech, a member of the Roche Group.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.